Published in Anal Chem on July 15, 2010
Quantum dot imaging platform for single-cell molecular profiling. Nat Commun (2013) 1.29
Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett (2012) 1.19
Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Anal Chem (Palo Alto Calif) (2013) 1.18
Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front Chem (2014) 0.97
Multicolor multicycle molecular profiling with quantum dots for single-cell analysis. Nat Protoc (2013) 0.91
Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay. J Transl Med (2012) 0.87
Nanoparticles for Improving Cancer Diagnosis. Mater Sci Eng R Rep (2013) 0.87
Single-band upconversion nanoprobes for multiplexed simultaneous in situ molecular mapping of cancer biomarkers. Nat Commun (2015) 0.86
Quantum dots for quantitative imaging: from single molecules to tissue. Cell Tissue Res (2015) 0.85
Spectral unmixing imaging of wavelength-responsive fluorescent probes: an application for the real-time report of amyloid Beta species in Alzheimer's disease. Mol Imaging Biol (2012) 0.80
Biomedical Probes Based on Inorganic Nanoparticles for Electrochemical and Optical Spectroscopy Applications. Sensors (Basel) (2015) 0.78
Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases. Curr Cardiovasc Imaging Rep (2013) 0.77
Optimizing two-color semiconductor nanocrystal immunoassays in single well microtiter plate formats. Sensors (Basel) (2011) 0.77
Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences. OMICS (2014) 0.77
Simplistic attachment and multispectral imaging with semiconductor nanocrystals. Sensors (Basel) (2011) 0.76
Dual-color immunofluorescent labeling with quantum dots of the diabetes-associated proteins aldose reductase and Toll-like receptor 4 in the kidneys of diabetic rats. Int J Nanomedicine (2015) 0.75
Quantum dots for live cells, in vivo imaging, and diagnostics. Science (2005) 21.62
Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 16.38
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med (2010) 8.74
The use of nanocrystals in biological detection. Nat Biotechnol (2004) 8.34
In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol (2005) 3.92
Nanotechnology applications in cancer. Annu Rev Biomed Eng (2007) 3.88
The biology of Hodgkin's lymphoma. Nat Rev Cancer (2008) 3.31
Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev (2008) 3.18
miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat Methods (2009) 3.03
Molecular profiling of human cancer. Nat Rev Genet (2000) 2.64
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc (2007) 2.45
Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. J Biomed Opt (2005) 2.05
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer (2006) 1.96
Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn (2006) 1.63
Proteomics for cancer biomarker discovery. Clin Chem (2002) 1.57
Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol (2002) 1.51
Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots. Mod Pathol (2006) 1.42
Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano (2010) 1.31
Ultrasensitive, multiplexed detection of cancer biomarkers directly in serum by using a quantum dot-based microfluidic protein chip. ACS Nano (2010) 1.24
Quantum dots light up pathology. J Pathol (2008) 1.24
Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials (2009) 1.22
Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. Annu Rev Pathol (2009) 1.18
Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol (2009) 1.04
High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett (2006) 1.03
Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J Clin Pathol (1987) 1.01
Genomics and proteomics: application of novel technology to early detection and prevention of cancer. Cancer Detect Prev (2002) 1.00
The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. Mod Pathol (2007) 0.96
Quantitative multiplexed quantum dot immunohistochemistry. Biochem Biophys Res Commun (2008) 0.92
CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood (1996) 0.92
Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. Trends Biotechnol (2009) 0.90
Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers. Mod Pathol (2009) 0.90
Simultaneous and sensitive determination of multiplex chemical residues based on multicolor quantum dot probes. Biosens Bioelectron (2009) 0.84
Molecular single-cell analysis of Hodgkin and Reed-Sternberg cells. Mol Med Today (1995) 0.83
A practical approach to the diagnosis of Hodgkin lymphoma. Am J Clin Pathol (2002) 0.79
CD45 immunostaining in T-cell-rich B-cell lymphoma and lymphocyte predominance Hodgkin's disease. J Pathol (1997) 0.77
In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol (2004) 17.47
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol (2007) 7.33
Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res (2008) 5.67
Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol (2002) 4.93
In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol (2005) 3.92
Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev (2008) 3.18
Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc (2008) 2.79
Bioimaging: second window for in vivo imaging. Nat Nanotechnol (2009) 2.48
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc (2007) 2.45
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther (2006) 2.38
Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res (2004) 2.31
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano (2010) 2.27
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine (2008) 2.20
Self-assembled nanoparticle probes for recognition and detection of biomolecules. J Am Chem Soc (2002) 2.18
Alloyed semiconductor quantum dots: tuning the optical properties without changing the particle size. J Am Chem Soc (2003) 2.00
Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc (2007) 1.98
Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J Am Chem Soc (2007) 1.95
Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol (2006) 1.94
Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small (2009) 1.93
Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. J Biomed Opt (2002) 1.92
Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. Nucleic Acids Res (2004) 1.89
A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots. Phys Chem Chem Phys (2006) 1.88
Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res (2009) 1.86
Using solution-phase nanoparticles, surface-confined nanoparticle arrays and single nanoparticles as biological sensing platforms. J Fluoresc (2004) 1.73
Counting single native biomolecules and intact viruses with color-coded nanoparticles. Anal Chem (2006) 1.64
Tuning the optical and electronic properties of colloidal nanocrystals by lattice strain. Nat Nanotechnol (2008) 1.63
Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn (2006) 1.63
Spectroscopic tags using dye-embedded nanoparticles and surface-enhanced Raman scattering. Anal Chem (2003) 1.61
Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol (2009) 1.60
Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) (2010) 1.51
Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrast enhancement, detection sensitivity, and tissue penetration. Anal Chem (2010) 1.47
Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology (2009) 1.47
Semiconductor nanocrystals: structure, properties, and band gap engineering. Acc Chem Res (2010) 1.46
Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem Photobiol (2004) 1.36
Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles. Cancer Res (2011) 1.36
Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine (Lond) (2006) 1.32
Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano (2010) 1.31
Oxidative quenching and degradation of polymer-encapsulated quantum dots: new insights into the long-term fate and toxicity of nanocrystals in vivo. J Am Chem Soc (2008) 1.31
Nanotechnology applications in surgical oncology. Annu Rev Med (2010) 1.31
Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease. Clin Cancer Res (2012) 1.30
HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano (2009) 1.29
Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano (2013) 1.28
Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann Biomed Eng (2006) 1.26
Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands. J Am Chem Soc (2008) 1.26
Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation. Anal Chem (2006) 1.25
Next-generation quantum dots. Nat Biotechnol (2009) 1.25
Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther (2007) 1.21
Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Anal Chem (Palo Alto Calif) (2013) 1.18
Nanometer-scale mapping and single-molecule detection with color-coded nanoparticle probes. Proc Natl Acad Sci U S A (2008) 1.17
Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha. Biochem Biophys Res Commun (2006) 1.15
Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol (2003) 1.14
Quantum dot-encoded mesoporous beads with high brightness and uniformity: rapid readout using flow cytometry. Anal Chem (2004) 1.13
Chemical analysis and cellular imaging with quantum dots. Analyst (2004) 1.11
Surface-enhanced Raman nanoparticle beacons based on bioconjugated gold nanocrystals and long range plasmonic coupling. J Am Chem Soc (2008) 1.07
Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo. Annu Rev Phys Chem (2015) 1.04
Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings. Anal Chem (2008) 1.03
Etching colloidal gold nanocrystals with hyperbranched and multivalent polymers: a new route to fluorescent and water-soluble atomic clusters. J Am Chem Soc (2007) 1.03
Primary small bowel carcinoid tumor with bilateral breast metastases: report of 2 cases with different clinical presentations. Arch Pathol Lab Med (2004) 1.03
Bright and compact alloyed quantum dots with broadly tunable near-infrared absorption and fluorescence spectra through mercury cation exchange. J Am Chem Soc (2010) 1.01
Quantum dots for in vivo molecular and cellular imaging. Methods Mol Biol (2007) 1.00
CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC. Clin Cancer Res (2013) 0.99
Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles. ACS Nano (2011) 0.95
Stimuli-responsive SERS nanoparticles: conformational control of plasmonic coupling and surface Raman enhancement. J Am Chem Soc (2009) 0.94
A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model. ACS Nano (2011) 0.94
Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots. Urology (2009) 0.93
Metaplastic breast carcinoma with squamous differentiation: molecular and clinical analysis of six cases. Breast J (2005) 0.93
Re-examining the origins of spectral blinking in single-molecule and single-nanoparticle SERS. Faraday Discuss (2006) 0.91
Compact quantum dots for single-molecule imaging. J Vis Exp (2012) 0.90
Expression of e-cadherin in high-risk breast cancer. J Cancer Res Clin Oncol (2004) 0.90
Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin. Cancer Res (2004) 0.90
Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. Trends Biotechnol (2009) 0.90
Quantitative 3D fluorescence technique for the analysis of en face preparations of arterial walls using quantum dot nanocrystals and two-photon excitation laser scanning microscopy. Am J Physiol Regul Integr Comp Physiol (2005) 0.90
Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head Neck (2009) 0.89
Proton-Resistant Quantum Dots: Stability in Gastrointestinal Fluids and Implications for Oral Delivery of Nanoparticle Agents. Nano Res (2009) 0.87
Imaging dynamic cellular events with quantum dots The bright future. Biochem (Lond) (2010) 0.86
An integrated widefield imaging and spectroscopy system for contrast-enhanced, image-guided resection of tumors. IEEE Trans Biomed Eng (2015) 0.86
Real-time detection of virus particles and viral protein expression with two-color nanoparticle probes. J Virol (2005) 0.85
Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population. Int J Clin Oncol (2004) 0.85
Quantum dots: emerging applications in urologic oncology. Urol Oncol (2008) 0.84
Anchoring molecular chromophores to colloidal gold nanocrystals: surface-enhanced Raman evidence for strong electronic coupling and irreversible structural locking. J Am Chem Soc (2012) 0.84
A new class of far-red and near-infrared biological labels based on alloyed semiconductor quantum dots. J Nanosci Nanotechnol (2004) 0.83
Single-bead immunoassays using magnetic microparticles and spectral-shifting quantum dots. J Agric Food Chem (2007) 0.83
The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas. Ann Surg (2015) 0.83
Molecular imaging to identify tumor recurrence following chemoradiation in a hostile surgical environment. Mol Imaging (2014) 0.82
Quantum dot-encoded beads. Methods Mol Biol (2005) 0.82
Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots. Int J Nanomedicine (2006) 0.82
One-pot synthesis, encapsulation, and solubilization of size-tuned quantum dots with amphiphilic multidentate ligands. J Am Chem Soc (2008) 0.81
Multidentate-protected colloidal gold nanocrystals: pH control of cooperative precipitation and surface layer shedding. J Am Chem Soc (2011) 0.79
Nanocrystal synthesis in an amphibious bath: spontaneous generation of hydrophilic and hydrophobic surface coatings. Angew Chem Int Ed Engl (2008) 0.78
Bio-nano-informatics: an integrated information management system for personalized oncology. Conf Proc IEEE Eng Med Biol Soc (2006) 0.77
Compact and blinking-suppressed quantum dots for single-particle tracking in live cells. J Phys Chem B (2014) 0.77
New technology and clinical applications of nanomedicine: highlights of the second annual meeting of the American Academy of Nanomedicine (Part I). Nanomedicine (2006) 0.77
An unusual role of folate in the self-assembly of heparin-folate conjugates into nanoparticles. Nanoscale (2015) 0.75
Unmixing of spectrally similar quantum dots using filter selection. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
A stilbene-based fluoroionophore for copper ion sensing in both reduced and oxidized environments. Talanta (2010) 0.75